ORAL THERAPEUTICS AND PHARMACOLOGY
Online ISSN : 1884-4928
Print ISSN : 0288-1012
ISSN-L : 0288-1012
Amount of Oral Formulations of Drugs for Carcinoma Used at 10 National Univeristy Dental Hospitals in Japan
SHINTARO KIMURAITARU MUKAIYAMAAKIRA SUZUKIKATSUHISA ASAMIYUTAKA MASUIKEYUKITAKA BANDOKATSUSHI FURUNOMICHIO KUMAGAIHIRONOBU KARASAWAATSUSHI BABA
Author information
JOURNAL FREE ACCESS

1998 Volume 17 Issue 2 Pages 61-65

Details
Abstract
The total number of prescriptions and the total amount of oral drugs for carcinoma purchased at 10 national university dental hospitals in Japan were investigated. During the fiscal year, Apr. 1, 1995 to Mar. 31, 1996, the total number of prescriptions for ambulatory patients at the 10 hospitals was 101, 707. They included 2, 646 prescriptions of anticancer drugs, which was 2.06 % (2, 646/101, 707) of all prescriptions. The most prescribed drug for carcinoma at the 10 hospitals surveyed was UFT®, with 206, 975 × 100mg doses dispensed per year. A small amount of off-labeling drugs such as Ubenimex (Bestatin® ), PSK (Krestin® ), Tegafur (Fental® ), and Doxifluridine (Furtulon® ) was used at six hospitals.
Content from these authors
© JAPANESE SOCIETY OF ORAL THERAPEUTICS AND PHARMACOLOGY
Previous article Next article
feedback
Top